promegestone and HIV
promegestone has been researched along with HIV in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Degenhardt, B; Li, H; Papadopoulos, V; Teper, G; Yao, Z | 1 |
Burton, DR; Nicolaou, KC; Rowcliffe, E; Sarlah, D; Shaw, DM; Wu, TR | 1 |
Burton, DR; Cravatt, BF; Cubitt, B; de la Torre, JC; Hessell, AJ; Lu, G; Nicolaou, KC; Nomura, DK; Sanchini, S; Sarlah, D; Wu, TR | 1 |
Other Studies
3 other study(ies) available for promegestone and HIV
Article | Year |
---|---|
Cholesterol binding at the cholesterol recognition/ interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide.
Topics: Amino Acid Sequence; Animals; Binding Sites; Cell Line; Cholesterol; Cloning, Molecular; Consensus Sequence; Gene Products, tat; HIV; Kinetics; Leydig Cells; Male; Mice; Mitochondria; Molecular Sequence Data; Progesterone; Promegestone; Receptors, GABA-A; Recombinant Proteins; tat Gene Products, Human Immunodeficiency Virus; Tritium | 2001 |
Total synthesis, revised structure, and biological evaluation of biyouyanagin A and analogues thereof.
Topics: Anti-HIV Agents; Cell Line; Cell Proliferation; Crystallography, X-Ray; Cytokines; Drug Evaluation, Preclinical; Furans; HIV; Humans; Hypericum; Inhibitory Concentration 50; Lipopolysaccharides; Lymphocytes; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Sensitivity and Specificity; Sesquiterpenes; Spiro Compounds; Stereoisomerism | 2008 |
Design, synthesis, and biological evaluation of a biyouyanagin compound library.
Topics: Anti-HIV Agents; Arenaviridae Infections; Arenavirus; Cell Line; HIV; HIV Infections; Humans; Molecular Structure; Sesquiterpenes; Spiro Compounds | 2011 |